Pharmacogenomics Market Outlook, Capacity and Capital Expenditure Forecast by 2029

-
Pharmacogenomics Market
Pharmacogenomics Market

Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a patient's genetic makeup to customise the medications they receive. Pharmacogenomics promises to offer a more customised (or exact) approach to the use of readily available medications in treating patients in this way.

Polymerase chain reaction (PCR), microarray, deoxyribonucleic acid (DNA) sequencing, mass spectrometry, and electrophoresis are only a few of the technologies used in pharmacogenomics. Pharmacogenomics Market uses genetic testing to assess the effectiveness of recently produced medications as well as the likelihood that a patient would develop a particular disease.

The Pharmacogenomics Market is anticipated to reach US$ 14,028.01 million in 2022 and grow at a CAGR of 11.1% during the following five years (2022-2030).

During the projected period, a growing need for precision medicine is anticipated to fuel market expansion. Increased demand for precision pharmaceuticals is anticipated to fuel market expansion throughout the projected period, along with an increase in the ageing population's susceptibility to disease. For instance, the National Cancer Institute reported in September 2020 that there will likely be 1,806,590 new instances of cancer diagnosed in the U.S., and there will likely be 606,520 cancer-related deaths.

Market growth is anticipated to be fueled by increasing inorganic expansion strategies by key players over the course of the projected period. The development of the global Pharmacogenomics Market is anticipated to be fueled by increasing inorganic growth tactics by leading players. For instance, Agena Bioscience, a global provider of genetic testing solutions and a division of Mesa Labs' Clinical Genomics Division, established a cooperation with Manchester University (MU) in November 2021 to increase awareness of and access to pharmacogenomics educational resources.

MU is a top organisation offering cutting-edge pharmacogenomic (PGx) education programmes in medical and lab sciences. Through this cooperation, Agena Bioscience will be able to advertise and provide its clients with the well-known MU PGx programmes, such as the Graduate Certificate in PGx or Master of Science in PGx degree.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more